Prevention is better than cure, except when it comes to the prices you can charge and the profits for your shareholders, in which case prevention is a losers’ racket.
As the US hits a 33-year high in measles infections, there is now a "race" to find a treatment for the disease.
One pharma company "is banking on a continuing decline in vaccination rates to fuel a need for measles treatments—and in turn, more investor interest"
🎁 link
The Race to Find a Measles Treatment as Infections Surge
The measles vaccine was so effective the disease was considered eliminated in the U.S., but a resurgence of outbreaks is spurring a need for drugs.
